Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Good Morning! Latin America.
Press releases published on August 14, 2025
24/7 Market News: LIXTE Biotech Advances Precision Oncology Pipeline with Multiple Phase 1B/2 Trial Readouts Expected in 2H 2025
GlobeNewswire
·
August 14, 2025
DENVER, Aug. 14, 2025 (GLOBE NEWSWIRE) -- 247marketnews.com, a pioneer in digital media dedicated to the swift distribution of financial market news and corporate information, spotlights LIXTE Biotechnology Holdings (Nasdaq: LIXT), a clinical-stage …
Connect Biopharma Teams with Ickey Woods and the Jovante Woods Foundation to Expand Asthma Education Program Nationwide
GlobeNewswire
·
August 14, 2025
Company and Former Cincinnati Bengals Running Back Known for the “Ickey Shuffle” Collaborate to Raise Awareness and Drive Asthma Education with Focus on Acute Attacks SAN DIEGO and CINCINNATI, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings …
Halda Therapeutics Receives FDA Fast Track Designation for HLD-0915 for the Treatment of Metastatic Castration-Resistant Prostate Cancer
GlobeNewswire
·
August 14, 2025
NEW HAVEN, Conn., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Halda Therapeutics, a clinical-stage biotechnology company developing a novel class of therapies called RIPTAC™ Therapeutics, today announced that the U.S. Food and Drug Administration (FDA) granted Fast …
Cocrystal Pharma Reports Second Quarter 2025 Financial Results and Provides Updates on its Antiviral Drug-Development Programs
GlobeNewswire
·
August 14, 2025
Favorable CDI-988 Phase 1 safety and tolerability reported Challenge study with CDI-988 as a norovirus preventive and treatment planned later this year BOTHELL, Wash., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or …
Orchestra BioMed Announces Publication of AVIM Therapy Clinical Data in JACC: Advances Demonstrating Potential to Improve Cardiac Function in Patients with Hypertension and Diastolic Dysfunction
GlobeNewswire
·
August 14, 2025
Echocardiographic data analysis demonstrated favorable impact of atrioventricular interval modulation (“AVIM”) therapy on MODERATO II study patients with diastolic dysfunction, a key component in the development of heart failure with preserved ejection …
Entrée Resources Announces Second Quarter 2025 Results
GlobeNewswire
·
August 14, 2025
VANCOUVER, British Columbia, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Entrée Resources Ltd. (TSX:ETG; OTCQB:ERLFF – the “Company” or “Entrée”) has today filed its interim financial results for the second quarter ended June 30, 2025. All numbers are in U.S. …
Integral Metals Reports Over 1% TREE Soil Geochemical Anomaly at the Burntwood Project
GlobeNewswire
·
August 14, 2025
CALGARY, Alberta, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Integral Metals Corp. (CSE: INTG | OTC: ITGLF | FSE: ZK9) (the “Company” or “Integral”) is pleased to report highly encouraging results from the 2024 soil geochemistry program completed at its Burntwood …
Vortex Energy Successfully Deploys ANT Sensors at Robinsons River Salt Project
GlobeNewswire
·
August 14, 2025
VANCOUVER, British Columbia, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Vortex Energy Corp. (CSE: VRTX) (OTC: VTECF) (FSE: AA3) (“Vortex” or the “Company”) is pleased to announce that all Ambient Noise Tomography (“ANT”) sensors have been successfully deployed …
LYNO AI Presale Surpasses 259K Tokens Sold as Early Bird Stage Nears Completion
GlobeNewswire
·
August 14, 2025
ROAD TOWN, British Virgin Islands, Aug. 14, 2025 (GLOBE NEWSWIRE) -- LYNO AI today announced that its Early Bird presale stage has exceeded expectations, with over 265,000 tokens sold ahead of schedule. This rapid uptake highlights strong investor …
Avicanna Reports Q2 2025
GlobeNewswire
·
August 14, 2025
TORONTO, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based …
Lexeo Therapeutics Reports Second Quarter 2025 Financial Results and Operational Highlights
GlobeNewswire
·
August 14, 2025
Breakthrough Therapy designation granted for LX2006 based on interim data from Phase I/II trials demonstrating clinically meaningful improvements in cardiac and neurologic measures of Friedreich ataxia LX2006 selected for FDA Chemistry, Manufacturing, and …
First American Uranium Announces Non-Brokered Private Placement of Shares
GlobeNewswire
·
August 14, 2025
- NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES - Vancouver, British Columbia, Aug. 14, 2025 (GLOBE NEWSWIRE) -- First American Uranium Inc. (CSE: URM) (FSE: IOR) (OTCPK: FAUMF) (the “Company”) is pleased to announce that it …
EvolveImmune Therapeutics Announces FDA Clearance of Investigational New Drug Application for EVOLVE104, a Novel Trispecific T Cell Engager with Integrated CD2 Costimulation
GlobeNewswire
·
August 14, 2025
First Program from EVOLVE T-Cell Engager Platform to Advance into Clinical Development Phase 1 Clinical Trial of EVOLVE104 to be Initiated in 2025 BRANFORD, Conn., Aug. 14, 2025 (GLOBE NEWSWIRE) -- EvolveImmune Therapeutics, an immuno-oncology company …
Bitget’s KCGI 2025 Wraps Up with Record-Breaking Participation and a $6M Prize Pool Across Global Challenges
GlobeNewswire
·
August 14, 2025
VICTORIA, Seychelles, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Bitget, the world’s leading cryptocurrency exchange and Web3 company, has successfully concluded the King’s Cup Global Invitational (KCGI) 2025, marking one of the most competitive and community- …
Prelude Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update
GlobeNewswire
·
August 14, 2025
PRT7732, once daily oral SMARCA2 degrader, currently enrolling at the seventh dosing cohort (125 mg); Company to provide an update with preliminary clinical data, including PK/PD, safety and initial clinical activity by year end 2025 Phase 1 study of …
Aya Gold & Silver Reports Strong Q2-2025 Results
GlobeNewswire
·
August 14, 2025
MONTREAL, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Aya Gold & Silver Inc. (TSX: AYA; OTCQX: AYASF) (“Aya” or the “Corporation”) today announced second quarter financial and operational results for the three-month period ended June 30, 2025. All amounts are in US …
atai Life Sciences Reports Second Quarter 2025 Financial Results and Recent Corporate Updates
GlobeNewswire
·
August 14, 2025
Planned strategic combination with Beckley Psytech expected to solidify position as global leader in transformative, psychedelic-based mental health therapies with a short time in-clinic Reported positive topline data from the core, blinded stage of the …
Oroco Congratulates Hudbay Minerals Inc.
GlobeNewswire
·
August 14, 2025
VANCOUVER, Canada, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Vancouver, CANADA. – August 14th, 2025 – Oroco Resource Corp. (TSX-V: OCO; OTCQB: ORRCF) (“Oroco” or “the Company”) extends its congratulations to Hudbay Minerals Inc. (“Hudbay”) for its agreement with …
HPQ Silicon Starts Production of HPQ ENDURA+ 18650 and 21700 Cells
GlobeNewswire
·
August 14, 2025
MONTREAL, Aug. 14, 2025 (GLOBE NEWSWIRE) -- HPQ Silicon Inc. (“HPQ” or the “Company”) (TSX-V: HPQ, OTCQB: HPQFF, FRA: O08), a technology company specializing in innovation in advanced materials and critical process development, announces the start of …
HPQ Silicium lance la production de cellules HPQ ENDURA+ 18650 et 21700
GlobeNewswire
·
August 14, 2025
MONTRÉAL, 14 août 2025 (GLOBE NEWSWIRE) -- HPQ Silicium inc. (« HPQ » ou « la Société ») (TSX-V: HPQ, OTCQB: HPQFF, FRA: O08), une entreprise technologique spécialisée dans l’innovation en matériaux avancés et le développement de procédés critiques annonce …